Websites using non-small cell lung cancer as a keyword
Here you can see a list of websites which are using non-small cell lung cancer as keyword according to our database.
Websites found: 9
Number of websited displayed: 9
Queries in the same category:
List of results:
XALKORI® (crizotinib) For ALK+ or ROS1+ mNSCLC Treatment | Safety Infohttp://site-overview.com/stats/xalkori.com
Learn about Rx XALKORI® (crizotinib) for treatment of ALK+ or ROS1+ non-small cell lung cancer that has spread to other parts of the body. See risks & benefits.
- Website Address renewal date: 16/5/23
- Domain Address Reg. date: 10/6/23
- Website address in use until: 18/6/23
Advanced NS NSCLC Treatment | ALIMTA (pemetrexed for injection)http://site-overview.com/stats/alimta.com
Learn how ALIMTA may help treat advanced nonsquamous non-small cell lung cancer (NSCLC). Find information about taking ALIMTA for the treatment of advanced NS NSCLC.
- Website Address renewal date: 17/8/13
- Domain Address Reg. date: 99/8/17
- Website address in use until: 18/8/17
OPDIVO® (nivolumab) | Patient Gatewayhttp://site-overview.com/stats/opdivo.com
OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.
- Website Address renewal date: 16/11/1
- Domain Address Reg. date: 12/11/6
- Website address in use until: 17/11/6
Treatment for certain lung, stomach, and colorectal tumors | CYRAMZA(R) (ramucirumab)http://site-overview.com/stats/cyramza.com
CYRAMZA® (ramucirumab), combined with other medications, is used for the treatment of patients with metastatic non-small cell lung cancer (NSCLC), advanced gastric cancer, gastroesophageal junction (GEJ) cancer, and metastatic colorectal cancer (CRC).
- Website Address renewal date: 17/10/1
- Domain Address Reg. date: 11/10/5
- Website address in use until: 18/10/5
Homehttp://site-overview.com/stats/iressa.com
Official site of IRESSA (gefitinib), indicated in Europe for the treatment of adults with locally advanced or metastatic NSCLC with activating mutations of EGFR-TK across all lines of therapy.
- Website Address renewal date: 16/8/9
- Domain Address Reg. date: 99/8/13
- Website address in use until: 17/8/13
OPDIVO® (nivolumab) | Information for Healthcare Professionalshttp://site-overview.com/stats/opdivohcp.com
Learn more about OPDIVO® (nivolumab). Prescribed medication to treat certain types of cancers. Read about its indications, clinical data and efficacy.
- Website Address renewal date: 17/2/27
- Domain Address Reg. date: 14/3/3
- Website address in use until: 18/3/3
For Healthcare Professionals | CYRAMZA® (ramucirumab)http://site-overview.com/stats/cyramzahcp.com
CYRAMZA, combined with other medications, is used for the treatment of patients with advanced gastric cancer or GEJ, metastatic non-small cell lung cancer (NSCLC), and metastatic colorectal cancer (mCRC).
- Website Address renewal date: 16/8/23
- Domain Address Reg. date: 13/8/27
- Website address in use until: 17/8/27
Patient Information | Alunbrig (brigatinib) for Patientshttp://site-overview.com/stats/alunbrig.com
Learn about Alunbrig (brigatinib), a treatment that could be right for you
- Website Address renewal date: 17/2/1
- Domain Address Reg. date: 15/10/28
- Website address in use until: 19/10/28